BIOMARKER:

EGFR mutation + MET mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR mutation + MET mutation EGFR mutation + MET mutation	Non Small Cell Lung Cancer NSCLC	EGFR mutation + MET mutation EGFR mutation + MET mutation	Non Small Cell Lung Cancer NSCLC	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials	Tyrosine kinase inhibitor Sensitive: C3 – Early Trials
EGFR mutation + MET mutation EGFR mutation + MET mutation	Non Small Cell Lung Cancer NSCLC	EGFR mutation + MET mutation EGFR mutation + MET mutation	Non Small Cell Lung Cancer NSCLC	osimertinib + savolitinib Sensitive: C3 – Early Trials	osimertinib + savolitinib Sensitive: C3 – Early Trials

Associations